Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • See Evidence submitted by expert panel for details.

Variant: NM_004992.3(MECP2):c.916C>T (p.Arg306Cys)

CA212529

11824 (ClinVar)

Gene: MECP2
Condition: Rett syndrome
Inheritance Mode: X-linked inheritance (dominant (HP:0001423))
Link to MONDO
UUID: 306280ba-f29e-479c-a220-4d3eb2bc93d9
Approved on: 2021-03-26
Published on: 2021-05-17

HGVS expressions

NM_004992.3:c.916C>T
NM_004992.3(MECP2):c.916C>T (p.Arg306Cys)
NC_000023.11:g.154030912G>A
CM000685.2:g.154030912G>A
NC_000023.10:g.153296363G>A
CM000685.1:g.153296363G>A
NC_000023.9:g.152949557G>A
NG_007107.2:g.111216C>T
NG_007107.3:g.111192C>T
ENST00000303391.11:c.916C>T
ENST00000453960.7:c.952C>T
ENST00000637917.1:n.90C>T
ENST00000303391.10:c.916C>T
ENST00000407218.5:c.*288C>T
ENST00000453960.6:c.952C>T
ENST00000619732.4:c.916C>T
ENST00000622433.4:c.902C>T
ENST00000628176.2:c.*288C>T
NM_001110792.1:c.952C>T
NM_001316337.1:c.637C>T
NM_001110792.2:c.952C>T
NM_001316337.2:c.637C>T
NM_001369391.2:c.637C>T
NM_001369392.2:c.637C>T
NM_001369393.2:c.637C>T
NM_001369394.1:c.637C>T
NM_001369394.2:c.637C>T
NM_001386137.1:c.247C>T
NM_001386138.1:c.247C>T
NM_001386139.1:c.247C>T
NM_004992.4:c.916C>T
More

Pathogenic

Met criteria codes 6
PS3_Supporting PS4 PP1 PM1 PM2_Supporting PS2_Very Strong

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Arg306Cys variant in MECP2 has been reported as a de novo occurrence (biological parentage both confirmed and unconfirmed) in at least 3 individuals with Rett Syndrome (PMID 10577905, 11309679, 19189931; internal database, GeneDx) (PS2_very strong). This variant has been observed in at least 4 other individuals with Rett syndrome (PMID 24511209, 23238081, RettBase) (PS4). The p.Arg306Cys variant occurs in the well-characterized transcriptional repression domain (TRD) functional domain of MECP2 (PMID 21326358, 23770565) (PM1). This variant is absent in gnomAD (PM2_supporting). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). In summary, p.Arg306Cys variant in MECP2 is classified as Pathogenic for Rett syndrome based on the ACMG/AMP criteria (PS2_very strong, PS4, PM1, PM2_supporting, PP3).
Met criteria codes
PS3_Supporting
Experimental studies have shown that this variant impacts protein function (PMID 23770565)
PS4
The p.XX variant has been observed in at least 4 other individuals with Rett syndrome (PMID: 10577905, 11309679, 19189931)
PP1
Met Variant observed to segregate with disease in 2 individuals in a single family. RettBASE Patient ID 28,29
PM1
Met NM_004992.3(MECP2):c.916C>T (p.Arg306Cys) is located in a mutational hot spot, NCoR/SMRT interaction (NID) ): aa 285-310
PM2_Supporting
The variant is absent in gnomAD (PM2)
PS2_Very Strong
The p.Arg306Cys variant in MECP2 has been reported as a de novo occurrence (biological parentage both confirmed and unconfirmed) in at least 3 individuals with Rett syndrome (PMID 10577905; internal database, GeneDx).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.